title: Novel analogs and stereoisomers of the marine toxin neodysiherbaine with specificity for kainate receptors.
abstract: Antagonists for kainate receptors (KARs), a family of glutamategated ion channels, are efficacious in a number of animal models of neuropathologies, including epilepsy, migraine pain, and anxiety. To produce molecules with novel selectivities for kainate receptors, we generated three sets of analogs related to the natural marine convulsant neodysiherbaine (neoDH), and we characterized their pharmacological profiles. Radioligand displacement assays with recombinant alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) and KARs demonstrated that functional groups at two positions on the neoDH molecule are critical pharmacological determinants; only binding to the glutamate receptor (GluR)5-2a subunit was relatively insensitive to structural modifications of the critical functional groups. NeoDH analogs in which the l-glutamate congener was disrupted by epimerization retained low affinity for GluR5-2a and GluR6a KAR subunits. Most of the analogs showed agonist activity in electrophysiological recordings from human embryonic kidney-T/17 cells expressing GluR5-2a KARs, similar to the natural convulsant neoDH. In contrast, 2,4-epi-neoDH inhibited glutamate currents evoked from both GluR5-2a and GluR6a receptor-expressing cells. Therefore, this compound represents the first compound to exhibit functional antagonist activity on GluR5-2a and GluR6a KAR subunits without concurrent activity on AMPA receptor subunits. Finally, binding affinity of the synthetic ligands for the GluR5-2a subunit closely correlated with their seizurogenic potency, strongly supporting a role for receptors containing this subunit in the convulsant reaction to KAR agonists. The analogs described here offer further insight into structural determinants of ligand selectivity for KARs and potentially represent useful pharmacological tools for studying the role of KARs in synaptic physiology and pathology.
authors.affiliation: Department of Molecular Pharmacology and Biological Chemistry, Northwestern University Feinberg School of Medicine, 303 E. Chicago Ave., Chicago, IL 60611, USA.
authors.forename: L Leanne
authors.initials: LL
authors.lastname: Lash
authors.forename: James M
authors.initials: JM
authors.lastname: Sanders
authors.forename: Nobuyuki
authors.initials: N
authors.lastname: Akiyama
authors.forename: Muneo
authors.initials: M
authors.lastname: Shoji
authors.forename: Pekka
authors.initials: P
authors.lastname: Postila
authors.forename: Olli T
authors.initials: OT
authors.lastname: Pentikäinen
authors.forename: Makoto
authors.initials: M
authors.lastname: Sasaki
authors.forename: Ryuichi
authors.initials: R
authors.lastname: Sakai
authors.forename: Geoffrey T
authors.initials: GT
authors.lastname: Swanson
mesh_terms: D000409:Alanine / Q000031:analogs & derivatives* / Q000737:chemistry / Q000494:pharmacology; D019086:Bridged Bicyclo Compounds, Heterocyclic / Q000737:chemistry* / Q000494:pharmacology*; D002460:Cell Line; D006801:Humans; D008387:Marine Toxins / Q000737:chemistry* / Q000494:pharmacology*; D018092:Kainic Acid Receptors / Q000037:antagonists & inhibitors* / Q000502:physiology; D013237:Stereoisomerism
chemical_list: D000409:Alanine; D019086:Bridged Bicyclo Compounds, Heterocyclic; D008387:Marine Toxins; D018092:Kainic Acid Receptors; C438974:neodysiherbaine A